Henry Schein, Inc. (NASDAQ:HSIC) Director Barry J. Alperin sold 5,796 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the transaction, the director now owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Henry Schein, Inc. (NASDAQ HSIC) opened at $71.10 on Wednesday. Henry Schein, Inc. has a 1 year low of $65.28 and a 1 year high of $93.50. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86. The company has a market cap of $11,176.72, a PE ratio of 19.98, a price-to-earnings-growth ratio of 2.00 and a beta of 0.99.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Monday, November 6th. The company reported $0.87 EPS for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The company had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. During the same period in the previous year, the company earned $0.84 EPS. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. equities research analysts forecast that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.
HSIC has been the subject of a number of research analyst reports. Credit Suisse Group restated a “hold” rating and set a $87.50 price objective on shares of Henry Schein in a research report on Tuesday, August 29th. Jefferies Group reaffirmed a “hold” rating and set a $88.50 target price on shares of Henry Schein in a report on Thursday, September 28th. Zacks Investment Research lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, November 13th. Robert W. Baird set a $95.00 target price on shares of Henry Schein and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Craig Hallum raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Tuesday, November 7th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have given a buy rating to the company’s stock. Henry Schein currently has an average rating of “Hold” and an average target price of $88.36.
Several institutional investors and hedge funds have recently modified their holdings of HSIC. Alecta Pensionsforsakring Omsesidigt lifted its position in shares of Henry Schein by 112.0% during the third quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after purchasing an additional 2,806,990 shares in the last quarter. Mackenzie Financial Corp lifted its position in shares of Henry Schein by 106.0% during the third quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock worth $322,896,000 after purchasing an additional 2,026,867 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Henry Schein by 92.1% during the third quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock worth $230,777,000 after purchasing an additional 1,349,333 shares in the last quarter. Atlanta Capital Management Co. L L C raised its holdings in Henry Schein by 99.4% in the third quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock valued at $204,405,000 after acquiring an additional 1,242,849 shares in the last quarter. Finally, Neuberger Berman Group LLC raised its holdings in Henry Schein by 95.9% in the third quarter. Neuberger Berman Group LLC now owns 2,475,058 shares of the company’s stock valued at $202,930,000 after acquiring an additional 1,211,743 shares in the last quarter. 91.75% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This article was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.com-unik.info/2017/12/06/barry-j-alperin-sells-5796-shares-of-henry-schein-inc-hsic-stock.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.